Dear Editor,
We read with interest, the commentary on our Cochrane systematic review on the test accuracy of pulse oximetry screening (POS) for critical congenital heart defects (CCHD) in newborn infants [1] by Oddie and McGuire [2] . We are grateful to the authors for appraising our work and welcome the wider dissemination of Cochrane reviews into the test accuracy of diagnostic tests. As the authors report, our data do support consensus recommendations for implementation of routine POS; however, we would like to make two comments in order to clarify the interpretation of our data. (i) a minor but important point is that a high specificity indicates a low false positive rate rather than a low false negative rate as stated in the commentary; false negatives will influence the sensitivity not the specificity. (ii) Of greater concern, we feel that the statement "… analysis showed that screening before 24 h after birth is less accurate than after 24 h" is erroneous and somewhat misleading. This interpretation may lead to misguided decision-making in terms of the screening algorithm adopted. It is true that the false positive rate for POS is higher if screening takes place in the first 24 h after birth; however, this is only half of the story. The sensitivity of POS (i.e., the ability to identify the target condition) was not significantly different between the 2 time periods -although sensitivity in the first 24 h was 79.5% compared with 73.6% after 24 h. More importantly and as we reported, most studies do not take into account the fact that many babies with a CCHD may present with symptoms within the first 24 h before screening takes place [1] and, therefore, do not become part of the screened cohort. As previous studies which screened after 24 h [3, 4] have reported, up to 50% of all babies with CCHD may present prior to screening and up to 20% of these present with acute cardiovascular collapse -the consequence that screening is trying to prevent. This scenario does not occur in studies in which babies are screened earlier [5] . In addition, babies with non-cardiac conditions such as respiratory and infective problems that are also detected by POS tend to present in the first 24 h, and although these are technically false positives, the clinical benefit of early detection of babies with these illnesses is clear.
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